Research

January 28, 2022

After examining Kristi Taylor in November 2020, J. William Lindsey, MD, a neurologist with UTHealth Houston, determined she was an ideal candidate for a clinical trial that is testing the efficacy and safety of fenebrutinib – a medication that inhibits the activity of certain malignant white blood cells – on the progression of disability in adult participants with primary progressive multiple sclerosis.

January 25, 2022

As health care evolves over the next 10 years, many providers will switch out their current electronic health record (EHR) system for a new one due to health system mergers or to keep up with the trends. Because EHR switches can cause care disruptions, researchers with The University of Texas Health Science Center at Houston (UTHealth Houston), U.S. Department of Veterans Affairs, and Baylor College of Medicine suggest following six key guidelines for an easy and safe transition.

January 18, 2022

Rates of cervical cancer screening have dropped in the U.S., with screening rates lowest among Asian and Hispanic women, as well as women who live in rural areas, don’t have insurance, or identify as LGBQ+, according to researchers with The University of Texas Health Science Center at Houston (UTHealth Houston).

January 12, 2022

A study designed to determine how magnetic resonance imaging (MRI) can be used to help clinicians treat patients with brain hemorrhages is underway at The University of Texas Health Science Center at Houston (UTHealth Houston).

January 11, 2022

An innovative academic drug discovery program at The University of Texas Health Science Center at Houston (UTHealth Houston) has earned Zhiqiang An, PhD, professor and director of the Texas Therapeutics Institute of the Brown Foundation Institute of Molecular Medicine at McGovern Medical School, a fellowship with the National Academy of Inventors (NAI).

January 5, 2022

For his research analyzing the time it takes to effectively administer anti-arrhythmic medication to cardiac arrest patients, Ryan Huebinger, MD, with The University of Texas Health Science Center at Houston (UTHealth Houston) has received the American Heart Association’s (AHA) Young Investigator Award.

December 20, 2021

 Maria E. Fernandez, PhD, the Lorne Bain Distinguished Professor in Public Health and Medicine, and professor of health promotion and behavioral science at UTHealth School of Public Health is the recipient of the 2022 Association of Schools and Programs of Public Health’s (ASPPH) Research Excellence Award. This distinguished award recognizes faculty who have devoted their careers to investigating public health issues. 

December 1, 2021

A secondary analysis of the Fragile Families and Child Wellbeing Study (Fragile Families) found a bi-directional relationship where a mother’s mental health symptoms impacted the child’s mental health symptoms and vice versa, according to researchers with Cizik School of Nursing at The University of Texas Health Science Center at Houston (UTHealth Houston).

June 3, 2021

A nasal therapy, built upon on the application of a new engineered IgM antibody therapy for COVID-19, was more effective than commonly used IgG antibodies at neutralizing the COVID-19 virus in animal models, according to research recently published by The University of Texas Health Science Center at Houston (UTHealth), The University of Texas Medical Branch at Galveston (UTMB Health), the University of Houston, and IGM Biosciences, Inc. 

October 15, 2020

To better understand the molecular basis of Down syndrome, a genetic disease that affects 1 in 750 infants born in the U.S., researchers at The University of Texas Health Science Center at Houston (UTHealth) have received a $3.1 million grant from the National Institutes of Health (NIH).